Navigation Links
246 Study Participants Reported the Health Benefits of the TA-65 Telomerase Activator
Date:8/23/2013

New York, NY (PRWEB) August 23, 2013

Studies have linked aging to the shortening of telomeres at the end of chromosomes. A longer telomere length ensures the accurate replication of DNA and maintenance of cellular health. It is believed that the degradation of telomeres causes a stage where the cells no longer can divide or they can mutate into cancer cells. The telomeres shorten up until they become too short causing cells to reach “replicative senescence” where they are unable to divide further bringing about the many problems that are linked with aging.

The only way to lengthen telomeres is through the activation of an enzyme called telomerase. At this time, the only natural way to activate the telomerase is through taking TA-65. Manufactured in TA Sciences laboratories, TA-65 is a highly purified and bio-enhanced molecule extracted from Astragalus Root.

Ivan Joksimovic, from the http://www.ta65doctor.com explained why this supplement is so special:

"This link between telomeres and aging makes TA-65 the most cutting-edge product talked about in the anti-aging world. Studies show that TA-65 given as an oral supplement has produced amazing results with telomerase activation. This reactivation of telomeres has improved health and signs of aging in many."

All studies using the TA-65 supplements are having these same amazing results. The list of aging signs that seem to reverse in some studies is quite remarkable.

Today, almost six months later, after the initial survey was released, more robust data was collected. The entire study population included 246 participants from 11 countries who volunteered to fill out a confidential survey questionnaire that contained questions about the subjective changes noticed after starting to take the TA-65 supplement.

84 percent of respondents recognized the progress in immune function, 73 percent were complimented by friends and family on improvements in their appearance, while 82 percent of participants saw great improvement in mood and sense of general well-being.

These findings are consistent with previous studies. Furthermore, 73 percent of participants also noticed improvements in the quality of their skin, 74 percent had less frequent colds (a testament to the improved immune function), 74 percent noticed improved energy, and 61 percent greater exercise tolerance and endurance.

A high percentage of respondents noted improvements in other areas, including quality of sleep, hair, vision and sexual function, while they also experienced improved joint mobility, as well as a reduction in joint pain.

Moreover, to determine the benefits of regular intake, participants were divided into two groups: those who were taking TA-65 less than six months, and those who were taking it longer.

The results showed a significant improvement in participants taking the pills for more than six months. The percentage of those who recognized the progress in immune function increased to 93 percent (from 72 percent with less than six months users), 91 percent were complimented by friends and family on improvements in their appearance compared with 50 percent, 90 percent of participants saw great improvement in mood and sense of general well-being, a jump from 71 percent, and 82 percent of those surveyed noticed improvements in the quality of their skin as well from 61 percent. Accordingly, the percentage of those who reported improvement in other areas also jumped. See the full study here.

Ivan explained that these results were expected:

"These results are excellent, but earlier studies have also shown high efficacy of TA-65 supplement. However, this new study gives us a broader picture of how the short-term use of these supplement makes a positive impact on well being and the most common signs of aging."

Whether these supplements become the new fountain of youth remains to be seen, but currently they are the most talked about supplements currently available to fight aging.

Read the full story at http://www.prweb.com/releases/ta-65/telomerase-activator/prweb11047476.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Single injection may revolutionize melanoma treatment, Moffitt study shows
2. Study helps explain increased melanoma risk in individuals with red hair
3. UCLA Nursing study suggests focus on lifestyle changes -- not weight loss -- is key to kids health
4. Study finds grandmothers who raise their grandkids struggle with depression
5. Study: Disease caused by repeat brain trauma in athletes may affect memory, mood, behavior
6. Case study collection diagnostic dilemmas hones physicians skills
7. Shocking New CDC Study Confirms U.S. Tick-Borne Disease Epidemic, Shows Lyme Disease Rates 10X Higher than Previously Reported
8. Penn Medicine study shows survivorship care plans empower cancer patients
9. UCLA study suggests iron is at core of Alzheimers disease
10. Brain cancer survival improved following FDA approval of bevacizumab, Mayo study finds
11. The concussed brain at work: fMRI study documents brain activation during concussion recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
(Date:6/23/2016)... , June 23, 2016 Leading BioSciences ... address medical conditions resulting from a breakdown of ... appointed Greg Doyle as chief executive ... BioSciences, executive management team and board of directors, ... financial officer. He will provide continued leadership and ...
Breaking Medicine Technology: